Delivery Order SPE2DB22D2218-SPE2DB25FR3CF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $9,153.24. This competitively awarded, firm fixed-price contract represents a single delivery order with an ultimate completion date of August 22, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3ml formulation) with a ceiling value of $19,962.14. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $1,136.92. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products, with a ceiling value of $1,566.65. This is a firm fixed price delivery order with an ultimate completion date of April 24, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Ozempic (0.25-0.5 mg/dose) pens in 3ml quantities, valued at $5,043.18. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, representing a non-competitive set-aside award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $9,656.92 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3 ml quantities. The contract represents a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $11,351.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ozempic 0.25–0.5 mg/dose pens in 3 mL vials, with a ceiling value of $6,565.81. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a $5,768.41 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml), with performance completion required by July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml vials, with a ceiling value of $16,813.02. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 26, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3CFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3mL) with a ceiling value of $31,330.28. The contract utilizes firm fixed price pricing and is classified as a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order is issued under AmerisourceBergen's larger DLA Troop Support Medical IDC (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen has demonstrated significant capacity to fulfill federal medical procurement requirements through competitive contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 8/6/25 |